NEUROMOLECULAR MEDICINE
期刊信息导读
- NEUROMOLECULAR MEDICINE基本信息
- NEUROMOLECULAR MEDICINE中科院SCI期刊分区
- 历年NEUROMOLECULAR MEDICINE影响因子趋势图
- NEUROMOLECULAR MEDICINE期刊英文简介
- NEUROMOLECULAR MEDICINE期刊中文简介
NEUROMOLECULAR MEDICINE基本信息
简称:NEUROMOL MED
中文名称:神经分子医学
研究方向:医学
2018-2019最新影响因子:2.576
SCI类别:SCIE
是否OA开放访问:No
出版地:UNITED STATES
出版周期:Quarterly
年文章数:47
涉及的研究方向:医学-神经科学
通讯方式:HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512
官方网站:http://link.springer.com/journal/12017
投稿网址:https://www.editorialmanager.com/nemm/
审稿速度:>12周,或约稿
平均录用比例:一般
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-1084%5BISSN%5D
NEUROMOLECULAR MEDICINE期刊英文简介
Published by Springer. ISSN: 1535-1084.Mark Mattson has been coeditor of the Journal of Molecular Neuroscience (JMN) and is now, with Christine van Broeckhoven and John Hardy, developing a more focused venue for the molecular genetics, biochemistry and cell biology of neurological disorders. NeuroMolecular Medicine (Part B of JMN) is committed to publishing high quality original research and critical reviews in these exciting areas of research. NeuroMolecular Medicine will encompass basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death, and will give special attention to synthetic research and reviews that aim to bridge genetic aberrancies with cellular and molecular mechanisms of neurological pathogenesis. The information published in NMM will provide a window into the future of molecular medicine for the nervous system.
NEUROMOLECULAR MEDICINE期刊中文简介
由施普林格出版。ISSN: 1535 - 1084。马克·马特森(Mark Mattson)是《分子神经科学杂志》(Journal of Molecular Neuroscience, JMN)的联合编辑,现在与克里斯汀·范布罗克霍文(Christine van Broeckhoven)和约翰·哈代(John Hardy)合作,为神经疾病的分子遗传学、生物化学和细胞生物学开发了一个更专注的场所。神经分子医学(JMN的B部分)致力于在这些令人兴奋的研究领域发表高质量的原创研究和批判性评论。神经分子医学将包括分子遗传学、信号转导、可塑性和细胞死亡领域的基础研究,并将特别关注旨在将遗传异常与神经发病的细胞和分子机制连接起来的合成研究和综述。发表在NMM上的信息将为神经系统的分子医学的未来提供一个窗口。
中科院SCI期刊分区:
NEUROMOLECULAR MEDICINE影响因子
获取相关优质资源获取2023中科院分区